• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Naomi Kresge

Stay informed with Naomi Kresge’s coverage and analysis.

Novo Nordisk CEO Lars Fruergaard Jorgensen Interview
Retail
Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By Sanne Wass, Naomi Kresge and BloombergMay 1, 2024
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
Health
Study shows Wegovy eases heart-failure symptoms for patients with diabetes—helpful to Novo as it argues insurers should pay for it
By Naomi Kresge and BloombergApril 6, 2024
WHO
Health
A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says
By Naomi Kresge, Angela Feliciano and BloombergMarch 1, 2024
Wegovy, an injectable prescription weight-loss medicine.
Health
A ‘game-changing’ study backs Wegovy use to cut heart attacks and strokes: ‘This is not just about weight and appearance’
By Madison Muller, Naomi Kresge and BloombergNovember 11, 2023
Drug trial
Health
Roche is using AI to find the hardest-to-find lung cancer patients, with a potential blockbuster drug on the line
By Naomi Kresge and BloombergOctober 22, 2023
Katalin Kariko and Drew Weissman
Health
COVID vaccine scientists claim Nobel Prize in medicine
By Naomi Kresge, Kati Pohjanpalo and BloombergOctober 2, 2023
Taking new weight-loss drug Wegovy by pill is just as effective as a shot, study finds
Health
Taking new weight-loss drug Wegovy by pill is just as effective as a shot, study finds
By Naomi Kresge and BloombergMay 22, 2023
Taking diet drug Wegovy for a year comes with a major added benefit, study finds
Health
Taking diet drug Wegovy for a year comes with a major added benefit, study finds
By Naomi Kresge and BloombergMay 19, 2023
University hospital staff in Scotland
Health
Arthritis drug reduced risk of COVID deaths by 13%, U.K. study finds
By Naomi Kresge and BloombergMarch 3, 2022
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
Health
Moderna says its COVID-19 booster vaccine delivers a massive increase in antibodies
By Suzi Ring, Naomi Kresge and BloombergDecember 20, 2021
Pfizer and BioNTech say booster dose is necessary to fight Omicron variant
Health
Pfizer and BioNTech say booster dose is necessary to fight Omicron variant
By Naomi Kresge and BloombergDecember 8, 2021
The two-shot regimen for younger kids is one-third the dose that’s given to people ages 12 and older.
Health
Europe approves Pfizer-BioNTech COVID-19 vaccine for kids from 5 to 11
By Naomi Kresge and BloombergNovember 25, 2021
Pfizer and BioNTech: Booster shot restores full COVID protection
Health
Pfizer and BioNTech: Booster shot restores full COVID protection
By Naomi Kresge and BloombergOctober 21, 2021
Most people don’t need COVID vaccine boosters yet, scientists say
Health
Most people don’t need COVID vaccine boosters yet, scientists say
By Naomi Kresge and BloombergSeptember 13, 2021
AC Immune shares surge on Alzheimer’s drug trial results
Health
AC Immune shares surge on Alzheimer’s drug trial results
By Naomi Kresge, James Paton and BloombergAugust 31, 2021
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Law
Egg companies made $1.22 billion in profit off a $6 carton — now they’re buying their way out of a price-fixing case with 53 million donated eggsplaceholder alt text
By Wyatte Grantham-Philips and The Associated PressJuly 2, 2026
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
AI
Meet the Zillennials: The luckiest micro-generation in the workforce, born between 1993 and 1998placeholder alt text
By Nick LichtenbergJuly 3, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.